Abiopharma

Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data ShowcasingXywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025